Citation Impact
Citing Papers
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Isolation and characterization
2006 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Breast cancer
2019 Standout
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
2004
Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
2010
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
2000
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
2010
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
INDUCTION CHEMOTHERAPY IN HEAD AND NECK CANCER
1999
Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.
1997
Inflammatory breast cancer: a review.
1992
Mitoxantrone
1991
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *
1996
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
2008 Standout
Primary vesical actinomycosis: A case report and literature review
2007
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
1998
Head and neck cancer
2008 Standout
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
2005 Standout
Treatment of head and neck cancer: the role of chemotherapy
1996
Clinically underdetected asymptomatic and symptomatic carotid stenosis as a late complication of radiotherapy in Chinese nasopharyngeal carcinoma patients
2001
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis
2006
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Improving Breast Cancer Surgery: A Classification and Quadrant per Quadrant Atlas for Oncoplastic Surgery
2010 Standout
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal
1995
CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer
2001
Nasopharyngeal carcinoma
2015 Standout
Oncoplastic Techniques Allow Extensive Resections for Breast-Conserving Therapy of Breast Carcinomas
2003
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
2002 Standout
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Dermal Lymphatic Emboli in Inflammatory and Noninflammatory Breast Cancer: A French-Tunisian Joint Study in 337 Patients
2005
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Management of malignant pleural effusions
2001 Standout
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer
2003
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
2014 Standout
Breast cancer complicated by pleural effusion: Patient characteristics and results of surgical management
1995
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Idarubicin
1991
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
1998 Standout
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
1997
Randomized Trial of Radiation Therapy Versus Concomitant Chemotherapy and Radiation Therapy for Advanced-Stage Oropharynx Carcinoma
1999 Standout
Axillary lymph nodes and breast cancer. A review
1995
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
1994
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
High-Dose Chemotherapy for Breast Cancer: The French PEGASE Experience
2003
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women
1999
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma
2004
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer
2020 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer
1996 Standout
Works of F Feuilhade being referenced
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
1999
Management of breast cancer in the elderly
1994
Induction chemotherapy in head and neck cancer: Results of a phase III trial
1992
External irradiation prior to conservative surgery for breast cancer treatment
1991
New cell lines of human breast cancer origin
1992
Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation
1988
[Effectiveness of hemodialysis in a case of acute methotrexate poisoning].
1991
Intrauterine device--associated pelvic actinomycosis: a rare disease mimicking advanced ovarian cancer: a case report.
1997
[Efficacy and toxicity of intrapleural mitoxantrone: apropos of 18 cases of pleural metastases of breast cancer].
1989
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
1994
[Randomized trial comparing mitoxantrone with adriamycin in advanced breast cancer].
1987
[Arterial stenosis after radiotherapy].
1990